Alx Oncology

ALXONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$229.540 M

$1.66 -2.35%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$101.7M

Loss-making

Shares outstanding

138,276,997

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#254Cartesian TherapeuticsRNAC$240.2M
#255Whitehawk TherapeuticsWHWK$230.3M
#256Alx OncologyALXO$229.5M
#257Natures Sunshine ProductsNATR$229.1M
#258Keros TherapeuticsKROS$227.6M

What if Alx Oncology were worth as much as…

Open the what-if tool →

Gold $30.3T

$218,937.75

Per share 131,890× higher

Bitcoin $1.72T

$12,437.38

Per share 7,492× higher

Nvidia $5.48T

$39,629.57

Per share 23,873× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Alx Oncology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.